Xeris Biopharma Holdings Inc share price logo

Xeris Biopharma Holdings Inc Share Price

NASDAQ: XERS

Small Cap

$5.43

-0.18

(-3.21%)

as on

Xeris Biopharma Holdings Inc Stock Performance

as on March 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.37
    $5.57
    downward going graph

    1.10%

    Downside

    2.58%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.81
    $10.08
    downward going graph

    29.93%

    Downside

    85.64%

    Upside

    downward going graph

Xeris Biopharma Holdings Inc share price movements today

Previous Close
$5.61
Open
$5.56
Volume
1.2M
Day's Low - High
$5.37 - $5.57
52 Week Low - High
$3.81 - $10.08

Xeris Biopharma Holdings Inc Historical Returns

1 Month Return
-19.32 %
3 Month Return
-26.02 %
1 Year Return
-1.45 %
3 Year Return
+ 302.22 %
5 Year Return
0 %

Xeris Biopharma Holdings Inc Stock Fundamentals & Key Indicators

Check Xeris Biopharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$967.3M

EPS (TTM)

0.1233

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

37.1M

Revenue (TTM)

291.8M

Profit Margin

0.19%

Return On Equity TTM

-617.16%

Xeris Biopharma Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xeris Biopharma Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Xeris Biopharma Holdings Inc image
Xeris Biopharma Holdings Inc
BUY$967.3MNANA0.19%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.5B118.37%136.938.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$117.5B108.96%30.2132.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$33.2BNA116.335.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.2B57.09%18.3231.41%

Stock Returns calculator for Xeris Biopharma Holdings Inc Stock including INR - Dollar returns

The Xeris Biopharma Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Xeris Biopharma Holdings Inc investment value today

Current value as on today

₹1,05,615

Returns

₹5,615

(+5.61%)

Returns from Xeris Biopharma Holdings Inc Stock

₹1,452 (-1.45%)

Dollar Returns*

₹7,067 (+7.07%)

Analyst Recommendation on Xeris Biopharma Holdings Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Xeris Biopharma Holdings Inc. Average target price of $11.14

Xeris Biopharma Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Xeris Biopharma Holdings Inc.

What analysts predicted

51.26%UPSIDE

Target Price

$11.14

Current Price

$5.43

Analyzed by

12 Analysts

Target

$11.14

Xeris Biopharma Holdings Inc target price $11.14, a slight upside of 51.26% compared to current price of $5.43. According to 12 analysts rating.

Xeris Biopharma Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Xeris Biopharma Holdings Inc Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:133% versus previous 30 day period

Xeris Biopharma Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
48
44
40
48
54
60
60
71
74
85
Gross Profit
40
34
34
37
40
50
51
56
63
66
Operating Income
-4
-9
-14
-8
-12
1
-3
4
6
16
EBITDA
-2
-3
-8
-3
-8
5
1
8
11
14
Interest Expense
6
7
7
7
7
7
7
7
7
7
Depreciation
2
3
3
3
3
3
3
3
3
3
Income Before Tax
-12
-13
-18
-14
-19
-5
-9
-1
0
11
Income Tax Expense
0
0
0
0
-3
-
-
-
-
-
Net Income
-12
-13
-18
-15
-15
-5
-9
-1
0
11
Net Profit Margin
-25.23%
-30.16%
-46.71%
-31.22%
-29.00%
-8.51%
-15.34%
-2.70%
0.83%
12.91%

Xeris Biopharma Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
2
2
2
49
110
163
203
291
Gross Profit
1
1
2
1
1
36
87
135
166
238
Operating Income
-13
-26
-59
-122
-122
-115
-81
-44
-33
24
EBITDA
-13
-26
-57
-119
-117
-113
-69
-23
-13
12
Interest Expense
0
0
2
7
7
7
14
26
33
29
Depreciation
-
0
0
1
1
1
12
13
12
12
Income Before Tax
-13
-26
-60
-126
-126
-122
-96
-63
-57
0
Income Tax Expense
0
0
1
0
0
0
-1
-1
-2
-
Net Income
-13
-26
-60
-125
-125
-122
-94
-62
-54
0
Net Profit Margin
-1228.74%
-1706.56%
-2437.32%
-4613.52%
-4613.52%
-247.48%
-85.86%
-37.98%
-27.00%
0.19%

Xeris Biopharma Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-13
-18
-15
-15
-5
-9
-1
0
11
Operating Cash Flow
6
-20
-10
-8
1
-10
0
18
20
Investing Cash Flow
14
-19
4
9
10
0
0
0
0
Financing Cash Flow
0
35
0
0
0
-3
0
13
0
Change in Cash
21
-4
-5
1
12
-13
0
32
19

Xeris Biopharma Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-60
-125
-91
-122
-94
-62
-54
0
Operating Cash Flow
-24
-56
-104
-80
-95
-102
-47
-36
28
Investing Cash Flow
0
-68
-2
-27
97
34
-6
4
0
Financing Cash Flow
35
128
80
126
27
127
-1
36
11
Change in Cash
9
3
-26
18
29
59
-54
4
39

Global Institutional Holdings in Xeris Biopharma Holdings Inc

Funds
Holdings
BlackRock Inc
6.92%
Qube Research & Technologies
2.03%
Nuveen, LLC
1.63%
UBS Group AG
1.03%
Two Sigma Investments LLC
1%
See all

Xeris Biopharma Holdings Inc News & Key Events

    Insights on Xeris Biopharma Holdings Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 4 quarters, -9.22M → 11.08M (in $), with an average increase of 294.4% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, XERS stock has moved up by 302.2%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, XERS has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 8 quarters, 40.63M → 85.80M (in $), with an average increase of 10.0% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.2% return, outperforming this stock by 25.7%

    About Xeris Biopharma Holdings Inc

    xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.
    OrganisationXeris Biopharma Holdings Inc
    Headquarters1375 West Fulton Street, Chicago, IL, United States, 60607
    IndustryHealth Technology
    CEOMr. John P. Shannon
    E-voting on sharesClick here to vote

    Key Management of Xeris Biopharma Holdings Inc

    Name

    Title

    Ms. Beth P. Hecht J.D.

    Chief Legal Officer & Corporate Secretary

    Ms. Allison Wey

    Senior Vice President of Investor Relations & Corporate Communications

    Mr. Brian Conner

    SVP of Quality and Chief Compliance & Risk Officer

    Ms. Kendal Korte

    Senior Vice President of Human Resources

    Dr. Anh Nguyen M.B.A., M.D.

    Chief Medical Officer

    Mr. John P. Shannon

    CEO & Director

    Mr. Kevin McCulloch

    President & COO

    Mr. Steven M. Pieper

    Chief Financial Officer

    FAQs

    What is Xeris Biopharma Holdings Inc share price today?

    Xeris Biopharma Holdings Inc share price today is $5.43 as on at the close of the market. Xeris Biopharma Holdings Inc share today touched a day high of $5.57 and a low of $5.37.

    What is the 52 week high and 52 week low for Xeris Biopharma Holdings Inc share?

    Xeris Biopharma Holdings Inc share touched a 52 week high of $10.08 on and a 52 week low of $3.81 on . Xeris Biopharma Holdings Inc stock price today i.e. is closed at $5.43,which is 46.13% down from its 52 week high and 42.71% up from its 52 week low.

    What is Xeris Biopharma Holdings Inc's market capitalisation today?

    Xeris Biopharma Holdings Inc market capitalisation is $0.00T as on .

    How to invest in Xeris Biopharma Holdings Inc Stock (XERS) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Xeris Biopharma Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xeris Biopharma Holdings Inc Shares that will get you 0.2762 shares as per Xeris Biopharma Holdings Inc share price of $5.43 per share as on March 19, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Xeris Biopharma Holdings Inc Stock (XERS) from India?

    Indian investors can start investing in Xeris Biopharma Holdings Inc (XERS) shares with as little as ₹92.634 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹926.34 in Xeris Biopharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xeris Biopharma Holdings Inc share’s latest price of $5.43 as on March 19, 2026 at 1:29 am IST, you will get 1.8416 shares of Xeris Biopharma Holdings Inc. Learn more about fractional shares .